Reference Tool
Compare Compounds
Place up to three reference compounds side by side to compare their molecular profile, pharmacokinetics, and handling.
| Attribute | foxo4-dri | ss-31-elamipretide | retatrutide |
|---|---|---|---|
| Field of Medicine | Geroscience · Senolytic Research | Mitochondrial Medicine · Cardiology Research | Endocrinology · Metabolic Research |
| Category | mitochondrial | mitochondrial | incretin |
| Formula | — | C32H49N9O5 | — |
| Molecular Weight | — | 639.79 Da | ~4731 Da |
| Sequence | Retro-inverso D-amino-acid FOXO4 fragment | D-Arg-Dmt-Lys-Phe-NH2 (Szeto-Schiller tetrapeptide) | 39-amino-acid triple agonist (GLP-1 / GIP / glucagon) |
| CAS Number | — | — | — |
| Half-Life | — | ~2–3 hours | ~6 days |
| Route (research) | — | — | Subcutaneous in research models |
| Onset / Steady-state | — | — | — |
| Lyophilized Storage | −20°C long term; 2–8°C short term (weeks). Protect from light. | −20°C long term; 2–8°C short term (weeks). Protect from light. | −20°C long term; 2–8°C short term (weeks). Protect from light. |
| Reconstituted Storage | 2–8°C, generally up to 14–28 days depending on compound. | 2–8°C, generally up to 14–28 days depending on compound. | 2–8°C, generally up to 14–28 days depending on compound. |